Several biotech firms and academic centers are leveraging artificial intelligence to accelerate diagnostics and therapeutic development. Adaptive Biotechnologies has integrated its ClonoSeq MRD assay into Roche’s Flatiron Health EMR to streamline community oncology testing workflows. Imagene AI raised $23 million in a Series B round to develop multi-modal digital pathology foundation models aimed at precision medicine. Complementing these advances, University of Illinois Urbana-Champaign researchers have combined AI with automated robotics to dramatically enhance enzyme engineering, while AI-powered methods have surfaced in other fields such as drone swarm control and early pancreatic cancer detection.